Plus Therapeutics, Inc. (PSTV) has a market capitalization of $13.67M and trades at $5.65. The 52-week range is 3.25-30.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -19.5, Earnings Per Share (EPS) of $-0.29, annual revenue of $5.21M.
The stock has a beta of 1.02, operates in the Healthcare sector.
